623 related articles for article (PubMed ID: 16848773)
21. Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation.
Rubin O; Delobel J; Prudent M; Lion N; Kohl K; Tucker EI; Tissot JD; Angelillo-Scherrer A
Transfusion; 2013 Aug; 53(8):1744-54. PubMed ID: 23228139
[TBL] [Abstract][Full Text] [Related]
22. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles.
Poitevin S; Cochery-Nouvellon E; Dupont A; Nguyen P
Thromb Haemost; 2007 Apr; 97(4):598-607. PubMed ID: 17393023
[TBL] [Abstract][Full Text] [Related]
23. The presence and release of tissue factor from human platelets.
Siddiqui FA; Desai H; Amirkhosravi A; Amaya M; Francis JL
Platelets; 2002 Jun; 13(4):247-53. PubMed ID: 12189027
[TBL] [Abstract][Full Text] [Related]
24. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms.
Joop K; Berckmans RJ; Nieuwland R; Berkhout J; Romijn FP; Hack CE; Sturk A
Thromb Haemost; 2001 May; 85(5):810-20. PubMed ID: 11372673
[TBL] [Abstract][Full Text] [Related]
25. Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons.
Lupu C; Kruithof EK; Kakkar VV; Lupu F
Thromb Haemost; 1999 Dec; 82(6):1652-8. PubMed ID: 10613651
[TBL] [Abstract][Full Text] [Related]
26. Tissue factor-bearing microparticles and cancer.
Zwicker JI
Semin Thromb Hemost; 2008 Mar; 34(2):195-8. PubMed ID: 18645925
[TBL] [Abstract][Full Text] [Related]
27. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
[TBL] [Abstract][Full Text] [Related]
28. Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available.
Wielders SJ; Béguin S; Hemker HC; Lindhout T
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1138-42. PubMed ID: 15072993
[TBL] [Abstract][Full Text] [Related]
29. Roles of platelets and factor XI in the initiation of blood coagulation by thrombin.
Walsh PN
Thromb Haemost; 2001 Jul; 86(1):75-82. PubMed ID: 11487044
[TBL] [Abstract][Full Text] [Related]
30. Tissue factor storage, synthesis and function in normal and activated human platelets.
Mezzano D; Matus V; Sáez CG; Pereira J; Panes O
Thromb Res; 2008; 122 Suppl 1():S31-6. PubMed ID: 18691497
[TBL] [Abstract][Full Text] [Related]
31. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
Hattori T; Khan MM; Colman RW; Edmunds LH
J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
[TBL] [Abstract][Full Text] [Related]
32. Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity.
Graff J; von Hentig N; Misselwitz F; Kubitza D; Becka M; Breddin HK; Harder S
J Clin Pharmacol; 2007 Nov; 47(11):1398-407. PubMed ID: 17873238
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor, phosphatidylserine and phosphatidylethanolamine.
Yates KR; Welsh J; Echrish HH; Greenman J; Maraveyas A; Madden LA
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):680-7. PubMed ID: 21941170
[TBL] [Abstract][Full Text] [Related]
34. Identification of tissue factor and platelet-derived particles on leukocytes during cardiopulmonary bypass by flow cytometry and immunoelectron microscopy.
Chung J; Suzuki H; Tabuchi N; Sato K; Shibamiya A; Koyama T
Thromb Haemost; 2007 Aug; 98(2):368-74. PubMed ID: 17721619
[TBL] [Abstract][Full Text] [Related]
35. Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.
Somajo S; Koshiar RL; Norström E; Dahlbäck B
Thromb Res; 2014 Jul; 134(1):144-52. PubMed ID: 24835672
[TBL] [Abstract][Full Text] [Related]
36. Impairment of the hemostatic potential of platelets during storage as evaluated by flow cytometry, thrombin generation, and thrombelastography under conditions promoting formation of coated platelets.
Svendsen MS; Rojkjaer R; Kristensen AT; Salado-Jimena JA; Kjalke M; Johansson PI
Transfusion; 2007 Nov; 47(11):2057-65. PubMed ID: 17958535
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous tissue factor expression and phosphatidylserine exposure account for the highly procoagulant pattern of melanoma cell lines.
Kirszberg C; Lima LG; Da Silva de Oliveira A; Pickering W; Gray E; Barrowcliffe TW; Rumjanek VM; Monteiro RQ
Melanoma Res; 2009 Oct; 19(5):301-8. PubMed ID: 19550359
[TBL] [Abstract][Full Text] [Related]
38. Absence of platelet-dependent fibrin formation in a patient with Scott syndrome.
Wielders SJ; Broers J; ten Cate H; Collins PW; Bevers EM; Lindhout T
Thromb Haemost; 2009 Jul; 102(1):76-82. PubMed ID: 19572071
[TBL] [Abstract][Full Text] [Related]
39. Platelet coagulation-protein interactions.
Walsh PN
Semin Thromb Hemost; 2004 Aug; 30(4):461-71. PubMed ID: 15354267
[TBL] [Abstract][Full Text] [Related]
40. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.
Mackman N; Tilley RE; Key NS
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1687-93. PubMed ID: 17556654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
